Eaton Vance Management Invitae Corp Transaction History
Eaton Vance Management
- $67.5 Billion
- Q3 2022
A detailed history of Eaton Vance Management transactions in Invitae Corp stock. As of the latest transaction made, Eaton Vance Management holds 100,000 shares of NVTA stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
100,000
Previous 100,000
-0.0%
Holding current value
$0
Previous $244,000
0.82%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NVTA
# of Institutions
20Shares Held
1.92MCall Options Held
0Put Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA1.28MShares$02.19% of portfolio
-
Alphabet Inc. Mountain View, CA236KShares$00.0% of portfolio
-
Pathstone Family Office, LLC Englewood, NJ158KShares$00.0% of portfolio
-
Rayliant Investment Research Santa Monica, CA50.4KShares$00.09% of portfolio
-
American Portfolios Advisors Holbrook, NY47.8KShares$00.0% of portfolio
About Invitae Corp
- Ticker NVTA
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 235,266,000
- Description
- Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...